
Meropenem with Sodium Carbonate is a sterile, broad-spectrum carbapenem antibiotic mixture designed for intravenous administration to treat severe bacterial infections.
In the field of infectious disease management, the stability of carbapenem molecules is crucial for intravenous efficacy. Manufacturers specifically select Meropenem with Sodium Carbonate because the carbonate buffer prevents the rapid degradation of the Meropenem trihydrate crystal structure in aqueous solutions. For instance, it is a primary choice for treating bacterial meningitis and complicated skin infections. Consequently, it facilitates high-purity delivery of the active agent directly into the bloodstream. As a result, Zyntex ensures that our sterile material meets the most stringent endotoxin and particulate matter standards required for hospital use.
Moreover, Meropenem’s chemical profile is often studied alongside other sulfonated or methanesulfonated derivatives to optimize therapeutic windows. In advanced pharmacology research, its stability is frequently compared to APIs formulated with strong organic acids like Methanesulfonic acid (MSA), which is used in the synthesis of mesylate salt alternatives. This application allows for a broader understanding of beta-lactam stability. Undoubtedly, this pushes the boundaries of antimicrobial science. At the same time, for laboratory testing and purification of high-potency antibiotics, Methyl cyanoacetate is often utilized as a specialized intermediate in the synthesis of heterocyclic side chains. In short, our product serves as a foundational component for advanced hospital-grade anti-infective therapy.
Recently, scientific interest has focused on the metabolic interactions between broad-spectrum antibiotics and renal excretion enhancers. Researchers apply Meropenem in clinical models, sometimes examining its interaction with neurologic modifiers like Methocarbamol to ensure patient safety during multi-drug intensive care treatments. Because of this, Zyntex offers specialized moisture-protected and light-shielded packaging to maintain the sterility and potency of the antibiotic. Ultimately, you secure a reliable supply partner by choosing Zyntex. We balance technical pharmaceutical expertise with a deep commitment to patient safety. To conclude, our commitment to chemical excellence ensures that your injectable manufacturing processes achieve the highest levels of clinical reliability.
This sterile pharmaceutical mixture is specifically vital in the following four sectors:
Zyntex supplies Meropenem for severe infection management; thus supporting critical care and emergency medicine.
Used as a primary sterile API in the production of IV vials; consequently ensuring high bioavailability and rapid action.
Manufacturers use it for antimicrobial susceptibility testing; undoubtedly essential for monitoring bacterial resistance.
Zyntex provides high-purity sterile API for formulation studies; specifically to optimize beta-lactamase resistance.
| Parameter | Standard Value |
|---|---|
| Product Name | Meropenem with Sodium Carbonate (Sterile) |
| Assay (Meropenem) | Min. 98% (on anhydrous basis) |
| Bacterial Endotoxins | < 0.125 EU/mg |
| CAS Number | 96036-03-2 (Meropenem) / 497-19-8 (Na2CO3) |
⚠️ Safety & Handling: Meropenem with Sodium Carbonate must be handled in sterile environments. Therefore, avoid exposure to moisture and light. Patients with a history of penicillin hypersensitivity should be monitored closely.
For more detailed pharmacology and clinical drug profiles, visit: PubChem Database – Meropenem (96036-03-2)